CClinicalTrials.gg
CompletedNCT00441857DOSEUpdated Jul 6, 2007

Effect of Plant Stanols on Cholesterol Absorption

A Phase 4 interventional study of plant stanol consumption in Hypercholesterolemia, sponsored by Oy Foodfiles Ltd. Completed at 1 site in Finland. Open to participants aged 25 Years to 68 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2007-07-06.

Sponsored by Oy Foodfiles Ltd · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
25 Years to 68 Years
Sex
All
01

Study summary

This study aims to measure the effect of three different doses of plant stanols in margarine on the cholesterol absorption efficiency in subjects with mildly to moderately increased serum LDL cholesterol concentrations

Read the detailed description

Serum cholesterol lowering effect of plant sterols is well established and it is also known that plant stanols inhibit the absorption of cholesterol. However, there is lack of dose-response studies directly measuring the cholesterol absorption efficiency during prolonged consumption of plant stanols. Therefore this study aims to measure the cholesterol absorption efficiency at different plant stanol consumption levels using a stable isotope tracer method.

Subjects will be randomized in their study groups that consume 20 g of margarine with different doses of plants stanols (0.8, 1.6 and 2.0g) based on cholesterol absorption efficiency at screening (high and low absorbers randomised separately). Cholesterol absorption test with cholesterol tracer will be conducted twice: at baseline and after 2-3 weeks margarine consumption period.

Cholesterol absorption efficiency will also be examined by indirect method i.e. by following the concentrations of serum cholesterol precursors and plant sterols in blood. In addition serum total, LDL and HDL cholesterol and triglycerides are followed.

02

Conditions studied

  • Hypercholesterolemia

Keywords

  • plant sterols
  • plant stanols
  • cholesterol absorption
03

In context

Hypercholesterolemia

1,238 studies on the registry are indexed under Hypercholesterolemia; 109 are open to participants now.

This study's enrollment of 60 is below the median of 99 across 991 interventional studies indexed under Hypercholesterolemia.

Browse Hypercholesterolemia studies →

Lead sponsor

This is the only study on the registry with Oy Foodfiles Ltd as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 68 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • healthy adults with mild to moderate hypercholesterolemia

Exclusion criteria

Exclusion Criteria:

  • lipid lowering medication
  • pregnancy or lactation
  • severe diseases (inc. diabetes, unstable CVD, malignant diseases)
  • severe obesity
  • regular plant sterol consumption
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double
Enrollment
60 participants

Interventions

  • Behavioralplant stanol consumption
06

What researchers measure

Primary outcomes

  1. cholesterol absorption efficiency

Secondary outcomes

  1. changes in blood lipids

07

Study locations

1 site
  • Oy Foodfiles Ltd
    Kuopio, 70210, Finland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 6, 2007, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00441857
Lead sponsor
Oy Foodfiles Ltd
First posted
Mar 1, 2007
Start date
Mar 2007
Completion
May 2007
Last update
Jul 6, 2007

Study contacts

Sakari A Nieminen, MD
principal investigator · Oy Foodfiles Ltd

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion